Using machine learning, we identified a set of diagnostic plasma biomarkers (e.g., TRIM21, CASP8, PTN and CSF1) that had very high accuracy in differentiating COVID-19 from CAP, and outperformed standard laboratory parameters used in clinical practice. This evidence concerns the gene PTN and COVID-19.